| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Accelerated evolution and spread of multidrug-resistant Plasmodium falciparum takes down the latest first-line antimalarial drug in southeast Asia
|
Ménard, Didier
|
|
|
19 |
9 |
p. 916-917
|
artikel
|
| 2 |
Bloodstream infections and carbapenem-resistant Enterobacteriaceae in South Korea
|
Yoon, Eun-Jeong
|
|
|
19 |
9 |
p. 931-932
|
artikel
|
| 3 |
Carbapenem-resistant Klebsiella pneumoniae with low chlorhexidine susceptibility
|
Stein, Claudia
|
|
|
19 |
9 |
p. 932-933
|
artikel
|
| 4 |
Characterisation of infectious Ebola virus from the ongoing outbreak to guide response activities in the Democratic Republic of the Congo: a phylogenetic and in vitro analysis
|
McMullan, Laura K
|
|
|
19 |
9 |
p. 1023-1032
|
artikel
|
| 5 |
Correction to Lancet Infect Dis 2019; 19: 812
|
|
|
|
19 |
9 |
p. e301
|
artikel
|
| 6 |
Culture-negative cryptococcal meningitis
|
Ssebambulidde, Kenneth
|
|
|
19 |
9 |
p. 929-930
|
artikel
|
| 7 |
Determinants of dihydroartemisinin-piperaquine treatment failure in Plasmodium falciparum malaria in Cambodia, Thailand, and Vietnam: a prospective clinical, pharmacological, and genetic study
|
van der Pluijm, Rob W
|
|
|
19 |
9 |
p. 952-961
|
artikel
|
| 8 |
Devising a strategy for prevention of malaria in pregnant women in the Asia Pacific
|
Chico, R Matthew
|
|
|
19 |
9 |
p. 919-920
|
artikel
|
| 9 |
Dolutegravir becomes first choice for HIV
|
Rahimi, Susan
|
|
|
19 |
9 |
p. 937-938
|
artikel
|
| 10 |
Efficacy and safety of intermittent preventive treatment and intermittent screening and treatment versus single screening and treatment with dihydroartemisinin–piperaquine for the control of malaria in pregnancy in Indonesia: a cluster-randomised, open-label, superiority trial
|
Ahmed, Rukhsana
|
|
|
19 |
9 |
p. 973-987
|
artikel
|
| 11 |
Efficacy of live oral rotavirus vaccines
|
Zhou, Bo
|
|
|
19 |
9 |
p. 929
|
artikel
|
| 12 |
Evolution and expansion of multidrug-resistant malaria in southeast Asia: a genomic epidemiology study
|
Hamilton, William L
|
|
|
19 |
9 |
p. 943-951
|
artikel
|
| 13 |
First clinical trial of a MERS coronavirus DNA vaccine
|
Yoon, In-Kyu
|
|
|
19 |
9 |
p. 924-925
|
artikel
|
| 14 |
Herpes zoster in people who are immunocompromised: what are the options for prevention?
|
Warren-Gash, Charlotte
|
|
|
19 |
9 |
p. 922-924
|
artikel
|
| 15 |
Immunogenicity and safety of the adjuvanted recombinant zoster vaccine in adults with haematological malignancies: a phase 3, randomised, clinical trial and post-hoc efficacy analysis
|
Dagnew, Alemnew F
|
|
|
19 |
9 |
p. 988-1000
|
artikel
|
| 16 |
Infectious disease surveillance update
|
Zwizwai, Ruth
|
|
|
19 |
9 |
p. 938
|
artikel
|
| 17 |
Intermittent preventive treatment with dihydroartemisinin–piperaquine and risk of malaria following cessation in young Ugandan children: a double-blind, randomised, controlled trial
|
Muhindo, Mary K
|
|
|
19 |
9 |
p. 962-972
|
artikel
|
| 18 |
Johan Willem Mouton
|
Burki, Talha
|
|
|
19 |
9 |
p. 940
|
artikel
|
| 19 |
Malaria, hunger, and starvation in colonial Punjab
|
Bagcchi, Sanjeet
|
|
|
19 |
9 |
p. 941
|
artikel
|
| 20 |
Menstrual toxic shock syndrome: case report and systematic review of the literature
|
Berger, Selina
|
|
|
19 |
9 |
p. e313-e321
|
artikel
|
| 21 |
More medicines alone cannot ensure the treatment of neglected tropical diseases
|
Chami, Goylette F
|
|
|
19 |
9 |
p. e330-e336
|
artikel
|
| 22 |
Phase 3 trial of treating gonorrhoea with solithromycin
|
Fernandes, Prabhavathi
|
|
|
19 |
9 |
p. 928
|
artikel
|
| 23 |
Pronounced larva migrans with secondary MRSA infection
|
Jørgensen, Astrid-Helene Ravn
|
|
|
19 |
9 |
p. 1034
|
artikel
|
| 24 |
Pulmonary cryptococcosis mimicking lung cancer
|
Taniwaki, Masaya
|
|
|
19 |
9 |
p. 1033
|
artikel
|
| 25 |
Research brief
|
Cleghorn, Sean
|
|
|
19 |
9 |
p. 939
|
artikel
|
| 26 |
Safety and efficacy of inactivated varicella zoster virus vaccine in immunocompromised patients with malignancies: a two-arm, randomised, double-blind, phase 3 trial
|
Mullane, Kathleen M
|
|
|
19 |
9 |
p. 1001-1012
|
artikel
|
| 27 |
Safety and immunogenicity of an anti-Middle East respiratory syndrome coronavirus DNA vaccine: a phase 1, open-label, single-arm, dose-escalation trial
|
Modjarrad, Kayvon
|
|
|
19 |
9 |
p. 1013-1022
|
artikel
|
| 28 |
Scrutinising Lyme disease in the UK
|
The Lancet Infectious Diseases,
|
|
|
19 |
9 |
p. 915
|
artikel
|
| 29 |
Should use of online photographs be exempt from ethical guidelines?
|
Stewart, Jenell
|
|
|
19 |
9 |
p. 933-934
|
artikel
|
| 30 |
The effect of global change on mosquito-borne disease
|
Franklinos, Lydia H V
|
|
|
19 |
9 |
p. e302-e312
|
artikel
|
| 31 |
The evolving research agenda for paediatric tuberculosis infection
|
Seddon, James A
|
|
|
19 |
9 |
p. e322-e329
|
artikel
|
| 32 |
The unanticipated benefits of protecting young children from malaria
|
Cohee, Lauren M
|
|
|
19 |
9 |
p. 918-919
|
artikel
|
| 33 |
Typhoid Vi-conjugate vaccine for outbreak control in Zimbabwe
|
Olaru, Ioana D
|
|
|
19 |
9 |
p. 930
|
artikel
|
| 34 |
Unspeakable: the truth about HIV-tainted blood in Canada
|
Costa, Márcia Martinho
|
|
|
19 |
9 |
p. 942
|
artikel
|
| 35 |
Use of reverse genetics to inform Ebola outbreak responses
|
Cross, Robert W
|
|
|
19 |
9 |
p. 925-927
|
artikel
|
| 36 |
Value of observational data for multidrug-resistant tuberculosis
|
Rodriguez, Carly A
|
|
|
19 |
9 |
p. 930-931
|
artikel
|
| 37 |
Varicella zoster virus vaccine in patients with haematological malignancies
|
Ljungman, Per
|
|
|
19 |
9 |
p. 921-922
|
artikel
|
| 38 |
15 years of the ECDC
|
Burki, Talha
|
|
|
19 |
9 |
p. 935-936
|
artikel
|
Tijdschrift beschrijving